Int'l : +1(646) 600-5072 | query@kbvresearch.com
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Life Sciences Quality Management Software Market size is expected to reach $7.17 Billion by 2031, rising at a market growth of 12.6% CAGR during the forecast period.
As companies adopt a more integrated approach to operations, QMS software is increasingly being integrated with other enterprise systems, such as Enterprise Resource Planning (ERP), Manufacturing Execution Systems (MES), and Laboratory Information Management Systems (LIMS). This integration provides a holistic view of operations, enabling better decision-making and faster response times. Blockchain technology is gaining traction in the life sciences industry to enhance transparency and traceability.
The Data Management segment is experiencing a CAGR of 9.3 % during the forecast period. Managing and analyzing large volumes of data generated in the life sciences sector is paramount for ensuring quality and compliance with industry standards. Effective data management solutions enable companies to maintain data integrity, ensure traceability, and support critical decision-making processes. As the life sciences industry continues to generate vast amounts of data, the demand for robust data management solutions is expected to rise, further driving the growth of this segment.
The Cloud & Web-based segment led the maximum revenue in the Global Life Sciences Quality Management Software Market by Deployment Mode in 2023, thereby, achieving a market value of $5.3 billion by 2031. This substantial share is driven by the increasing preference for cloud-based solutions due to their scalability, cost-effectiveness, and ease of access. Cloud-based deployment allows life sciences companies to efficiently manage quality processes, ensure compliance, and facilitate collaboration across different geographic locations without significant upfront investment in IT infrastructure.
The Pharmaceutical Firms segment is growing at a CAGR of 11.7 % during the forecast period. This substantial share indicates the crucial role of quality management software in the pharmaceutical industry, where compliance with stringent regulatory standards and ensuring product quality are paramount. Pharmaceutical firms rely heavily on these software solutions to manage complex quality processes, from raw material sourcing to final product delivery, ensuring that every step adheres to the highest quality and safety standards.
Full Report: https://www.kbvresearch.com/life-sciences-quality-management-software-market/
The North America region dominated the Global Life Sciences Quality Management Software Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.6 billion by 2031. The Europe region is anticipated to grow at a CAGR of 12.2% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 13.2% during (2024 - 2031).
By Application
By Deployment Mode
By End Use
By Geography
Related Reports: